VIR - Vir Biotechnology - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VIR is currently covered by 8 analysts with an average price target of $18.81. This is a potential upside of $11.47 (156.27%) from yesterday's end of day stock price of $7.34.

Vir Biotechnology's activity chart (see below) currently has 62 price targets and 74 ratings on display. The stock rating distribution of VIR is 2.94% SELL, 20.59% HOLD and 76.47% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 56.78% with an average time for these price targets to be met of 150.08 days.

Highest price target for VIR is $110, Lowest price target is $12, average price target is $18.81.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 20-Nov-2024. First documented stock forecast 05-Nov-2019.

Currently out of the existing stock ratings of VIR, 1 are a SELL (2.94%), 7 are a HOLD (20.59%), 26 are a BUY (76.47%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$110

$102.55 (1376.51%)

$110

1 months ago
(20-Nov-2024)

1/13 (7.69%)

$103.07 (1487.30%)

128

Buy

$19

$11.55 (155.03%)

$19

1 months ago
(20-Nov-2024)

0/13 (0%)

$12.07 (174.17%)

Buy

$26

$18.55 (248.99%)

$28

1 months 16 days ago
(04-Nov-2024)

3/8 (37.5%)

$16.92 (186.34%)

99

Hold

$12

$4.55 (61.07%)

$10

7 months 17 days ago
(03-May-2024)

3/5 (60%)

$1.61 (15.50%)

21

$12

$4.55 (61.07%)

$15

1 years 1 months 14 days ago
(06-Nov-2023)

2/3 (66.67%)

$3.37 (39.05%)

108

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VIR (Vir Biotechnology) average time for price targets to be met?

On average it took 150.08 days on average for the stock forecasts to be realized with a an average price target met ratio 56.78

Which analyst has the current highest performing score on VIR (Vir Biotechnology) with a proven track record?

ANUPAM RAMA

Which analyst has the most public recommendations on VIR (Vir Biotechnology)?

Anupam Rama works at JPMORGAN and has 5 price targets and 5 ratings on VIR

Which analyst is the currently most bullish on VIR (Vir Biotechnology)?

Patrick Trucchio with highest potential upside - $102.55

Which analyst is the currently most reserved on VIR (Vir Biotechnology)?

Eric Joseph with lowest potential downside - $4.55

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?